scispace - formally typeset
Journal ArticleDOI

Metabolism and Pharmacokinetics of 3-n-Butylphthalide (NBP) in Humans: The Role of Cytochrome P450s and Alcohol Dehydrogenase in Biotransformation

TLDR
It is demonstrated that NBP was well absorbed and extensively metabolized by multiple enzymes to various metabolites prior to urinary excretion, and can undergo β-oxidation to yield phthalide-3-acetic acid in rat liver homogenate.
Abstract
3-n-Butylphthalide (NBP) is a cardiovascular drug currently used for the treatment of cerebral ischemia. The present study aims to investigate the metabolism, pharmacokinetics, and excretion of NBP in humans and identify the enzymes responsible for the formation of major metabolites. NBP underwent extensive metabolism after an oral administration of 200 mg NBP and 23 metabolites were identified in human plasma and urine. Principal metabolic pathways included hydroxylation on alkyl side chain, particularly at 3-, ω-1-, and ω-carbons, and further oxidation and conjugation. Approximately 81.6% of the dose was recovered in urine, mainly as NBP-11-oic acid (M5-2) and glucuronide conjugates of M5-2 and mono-hydroxylated products. 10-Keto-NBP (M2), 3-hydroxy-NBP (M3-1), 10-hydroxy-NBP (M3-2), and M5-2 were the major circulating metabolites, wherein the areas under the curve values were 1.6-, 2.9-, 10.3-, and 4.1-fold higher than that of NBP. Reference standards of these four metabolites were obtained through microbial biotransformation by Cunninghamella blakesleana. In vitro phenotyping studies demonstrated that multiple cytochrome P450 (P450) isoforms, especially CYP3A4, 2E1, and 1A2, were involved in the formation of M3-1, M3-2, and 11-hydroxy-NBP. Using M3-2 and 11-hydroxy-NBP as substrates, human subcellular fractions experiments revealed that P450, alcohol dehydrogenase, and aldehyde dehydrogenase catalyzed the generation of M2 and M5-2. Formation of M5-2 was much faster than that of M2, and M5-2 can undergo β-oxidation to yield phthalide-3-acetic acid in rat liver homogenate. Overall, our study demonstrated that NBP was well absorbed and extensively metabolized by multiple enzymes to various metabolites prior to urinary excretion.

read more

Citations
More filters
Journal ArticleDOI

Phthalides and Phthalans: Synthetic Methodologies and Their Applications in the Total Synthesis

TL;DR: In this paper, the authors present Phthalides A 1.1.1, a 1.5-approximation of the original Phthalide A 1, which they call
Journal ArticleDOI

New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites

TL;DR: Current SC prevalence is reviewed, the necessity for SC metabolism investigation is established and the advantages and disadvantages of multiple metabolic approaches are compared, and a practical strategy to select optimal urinary marker metabolites for SCs is devised.
Journal ArticleDOI

Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.

TL;DR: Novel SCs are incubated with human hepatocytes, the most abundant and characteristic metabolites are identified with high‐resolution mass spectrometry, and proposed hepatocyte marker metabolites are confirmed in authentic positive urine samples.
Journal ArticleDOI

A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its Derivatives

TL;DR: Recent advances pertaining to the neuroprotective mechanisms of NBP-derived compounds and the possibility of their clinical implementation in the management of various neurological conditions are discussed.
Journal ArticleDOI

High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes

TL;DR: High-resolution mass spectrometry was used to identify optimal metabolite markers for laboratories to identify ThJ-018 and THJ-2201 intake and link observed adverse events to these new synthetic cannabinoids.
References
More filters
Journal ArticleDOI

Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes.

TL;DR: The reaction phenotype of a drug is assigned by integrating all three data sets (r, % TNR, and % I), and the normalized rate for each rCYP is expressed as a percent of the TNR (% TNR).
Journal ArticleDOI

Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review

TL;DR: The cumulative consequences of VPA therapy in inborn errors of metabolism (IEMs) and the importance of recognizing an underlying IEM in cases of Vpa-induced steatosis and acute liver toxicity are two different concepts that will be emphasized.
Journal ArticleDOI

Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11.

TL;DR: CYP4F2 and CYP4A11 underlie conversion of AA to 20-HETE, a natriuretic and vasoactive eicosanoid, in human kidney, and considering their proximal tubular localization, these P450 enzymes may partake in pivotal renal functions, including the regulation of salt and water balance, and arterial blood pressure itself.
Journal ArticleDOI

Mass defect filter technique and its applications to drug metabolite identification by high‐resolution mass spectrometry

TL;DR: The mass defect patterns of various classes of drug metabolites and the basic principles of the MDF approach are reviewed, which enables high-resolution mass spectrometers to be utilized for detecting both predicted and unexpected drug metabolites based on narrow, well-defined mass defect ranges for these metabolites.
Journal ArticleDOI

Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes.

TL;DR: An in vivo rat study validated earlier independent work that poly- and per-fluoroalkyl carboxylates were metabolites of FTOHs, but the detection of several novel metabolites prompted us to examine their pathways in greater detail using isolated rat hepatocytes.
Related Papers (5)